HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Altered characteristics of B16 melanoma cells induced by chemically crosslinking fibronectin to cell surfaces.

Abstract
The loss of fibronectin from tumor cell surfaces has been correlated with an increased incidence of metastases. To determine directly whether cell surface fibronectin influences the metastatic potential of solid tumors, we chemically crosslinked fibronectin to B16 murine melanoma cells using a photosensitive heterobifunctional crosslinking reagent, N-succinimidyl-4-azidophenyl-1,3 dithiopropionate (SADP). Cell attachment to plastic surfaces was increased in cells to which fibronectin was attached; cell growth over a 24-hr period was not significantly affected by the addition of fibronectin. When C57BL/6 mice were injected with fibronectin-crosslinked B16 cells, there was a 63% reduction in the number of pulmonary nodules compared to untreated controls. These results are consistent with the hypothesis that fibronectin enhances the recognition and removal of tumor cells from the circulation, possibly by cells of the reticuloendothelial system.
AuthorsJ C Bowersox, A Richters, N Sorgente
JournalJournal of surgical oncology (J Surg Oncol) Vol. 29 Issue 1 Pg. 11-4 (May 1985) ISSN: 0022-4790 [Print] United States
PMID3990305 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Azides
  • Cross-Linking Reagents
  • Fibronectins
  • 3-((4-azidophenyl)dithio)propionic N-hydroxysuccinimide
Topics
  • Animals
  • Azides
  • Cell Adhesion
  • Cell Division
  • Cell Membrane (metabolism)
  • Cells, Cultured
  • Cross-Linking Reagents
  • Fibronectins (metabolism)
  • Melanoma (immunology, metabolism)
  • Mice
  • Mice, Inbred C57BL
  • Neoplasm Metastasis
  • Surface Properties

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: